Medpace Interest Expense from 2010 to 2024

MEDP Stock  USD 382.44  2.61  0.68%   
Medpace Holdings Interest Expense yearly trend continues to be relatively stable with very little volatility. Interest Expense is likely to grow to about -463.6 K this year. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2014-03-31
Previous Quarter
105 K
Current Value
1.8 M
Quarterly Volatility
2.6 M
 
Yuan Drop
 
Covid
Check Medpace Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medpace main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.5 M, Total Revenue of 2 B or Gross Profit of 278.6 M, as well as many exotic indicators such as Price To Sales Ratio of 3.3, Dividend Yield of 0.0011 or PTB Ratio of 17.69. Medpace financial statements analysis is a perfect complement when working with Medpace Holdings Valuation or Volatility modules.
  
This module can also supplement Medpace Holdings' financial leverage analysis and stock options assessment as well as various Medpace Holdings Technical models . Check out the analysis of Medpace Holdings Correlation against competitors.
To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.

Latest Medpace Holdings' Interest Expense Growth Pattern

Below is the plot of the Interest Expense of Medpace Holdings over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Medpace Holdings' Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medpace Holdings' overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Slightly volatile
   Interest Expense   
       Timeline  

Medpace Interest Expense Regression Statistics

Arithmetic Mean9,205,493
Geometric Mean0.00
Coefficient Of Variation103.82
Mean Deviation8,454,672
Median7,559,000
Standard Deviation9,557,372
Sample Variance91.3T
Range27.7M
R-Value(0.75)
Mean Square Error42.8T
R-Squared0.56
Significance0
Slope(1,606,272)
Total Sum of Squares1278.8T

Medpace Interest Expense History

2024-463.6 K
2023-488 K
20222.9 M
2021-105 K
2020307 K
20191.6 M
20188.2 M

About Medpace Holdings Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Medpace Holdings income statement, its balance sheet, and the statement of cash flows. Medpace Holdings investors use historical funamental indicators, such as Medpace Holdings's Interest Expense, to determine how well the company is positioned to perform in the future. Although Medpace Holdings investors may use each financial statement separately, they are all related. The changes in Medpace Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Medpace Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Medpace Holdings Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Medpace Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Expense-488 K-463.6 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medpace Holdings is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medpace Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medpace Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Medpace Holdings Stock:
Check out the analysis of Medpace Holdings Correlation against competitors.
To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.
Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Medpace Stock analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.165
Earnings Share
8.89
Revenue Per Share
61.384
Quarterly Revenue Growth
0.265
Return On Assets
0.1399
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.